Alvotech Biosciences India Pvt. Ltd., Koramangala, Bengaluru, India.
J Biosci. 2023;48.
Rare diseases (RDs) are those that affect a small fraction of the total population. In India, where resources are scarce, the healthcare infrastructure and policy framework are focused on mitigating diseases that affect a large number of people. As a result,many cases ofRDs remain unreported, undiagnosed, and untreated. To understandthe currentlevel of RD awareness among healthcare professionals (HCPs) and researchers, as they are key stakeholders in diagnosis, treatment, policy making, and drug development, we conducted a survey based on identification of an RD, time for diagnosis, treatment options, and relationship with family history and geographic location. The survey was divided into two parts, one for researchers and the other for healthcare professionals, each consisting of 22 questions. We observed that among all our respondents, 31% of researchers and 29% of HCPs did not know the time required for diagnosis of a rare disease they mentioned in the survey. They identified the importance of family history but failed to realize its association with geographic location. The results from the exploratory study can provide information for enabling larger studies to develop recommendations and policies that can improve awareness about RDs in healthcare communities.
罕见病是指那些仅影响总人口中一小部分的疾病。在资源匮乏的印度,医疗保健基础设施和政策框架的重点是减轻影响大量人群的疾病。因此,许多罕见病病例仍未报告、未确诊和未得到治疗。为了了解医疗保健专业人员(HCPs)和研究人员对罕见病的认知现状,因为他们是诊断、治疗、制定政策和药物开发的关键利益相关者,我们进行了一项基于识别罕见病、诊断时间、治疗选择以及与家族史和地理位置关系的调查。该调查分为两部分,一部分是针对研究人员的,另一部分是针对医疗保健专业人员的,每部分都有 22 个问题。我们观察到,在所有受访者中,31%的研究人员和 29%的 HCPs 不知道他们在调查中提到的罕见病的诊断所需时间。他们认识到家族史的重要性,但没有意识到它与地理位置的关联。探索性研究的结果可以为开展更大规模的研究提供信息,以制定建议和政策,从而提高医疗保健界对罕见病的认识。